We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SLACW
676
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$9K ﹤0.01%
131,029
-1,282
-1% -$193
2022 Q1
3 quarters
SFRWW
677
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$9K ﹤0.01%
237,619
– –
2021 Q1
7 quarters
BIOSW
678
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$9K ﹤0.01%
186,175
-1,822
-1% -$93
2022 Q1
3 quarters
BLNGW
679
DELISTED
Belong Acquisition Corp. Warrant
BLNGW
$9K ﹤0.01%
72,094
– –
2021 Q3
5 quarters
GEEXW
680
DELISTED
Games & Esports Experience Acquisition Corp. Warrants
GEEXW
$9K ﹤0.01%
233,953
– –
2022 Q1
3 quarters
NAACW
681
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$9K ﹤0.01%
460,510
– –
2021 Q1
7 quarters
AENTW icon
682
Alliance Entertainment Holding Corp Warrants
AENTW
$1.53M
$8K ﹤0.01%
119,417
-1,172
-1% -$96
2021 Q2
6 quarters
RMGCW icon
683
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$8K ﹤0.01%
190,094
– –
2021 Q2
6 quarters
ENERR
684
DELISTED
Accretion Acquisition Corp Right
ENERR
$8K ﹤0.01%
101,089
– –
2021 Q4
4 quarters
ARBGW
685
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$7K ﹤0.01%
158,411
– –
2021 Q1
7 quarters
WRAC.WS
686
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$7K ﹤0.01%
+154,487
New +$6.26K
2022 Q4
0 quarters
JTAIW icon
687
DELISTED
Jet.AI Inc. Warrant
JTAIW
$6K ﹤0.01%
203,852
– –
2022 Q3
1 quarter
SPECW icon
688
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$6K ﹤0.01%
238,622
– –
2022 Q1
3 quarters
PRPC.WS
689
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$6K ﹤0.01%
76,038
– –
2022 Q1
3 quarters
GLTA.WS
690
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$6K ﹤0.01%
119,312
– –
2021 Q3
5 quarters
GWIIW
691
DELISTED
Good Works II Acquisition Corp. Warrant
GWIIW
$6K ﹤0.01%
72,158
– –
2021 Q3
5 quarters
SEPAW icon
692
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$5K ﹤0.01%
+121,079
New +$7.24K
2022 Q4
0 quarters
PEPLW
693
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$5K ﹤0.01%
73,355
– –
2021 Q4
4 quarters
FICVW
694
DELISTED
Frontier Investment Corp Warrants
FICVW
$5K ﹤0.01%
33,582
– –
2021 Q3
5 quarters
CCVI.WS
695
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$5K ﹤0.01%
95,077
– –
2022 Q1
3 quarters
SDACW
696
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$5K ﹤0.01%
119,951
– –
2021 Q2
6 quarters
DNZ.WS
697
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$5K ﹤0.01%
88,913
– –
2022 Q1
3 quarters
MCAAW icon
698
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$4K ﹤0.01%
140,587
– –
2022 Q1
3 quarters
TRONW icon
699
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$4K ﹤0.01%
117,986
– –
2021 Q3
5 quarters
COOLW icon
700
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$4K ﹤0.01%
112,855
– –
2021 Q1
7 quarters
26 27
28
29 30

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.